[EN] USE OF COMPOUNDS AS FUNCTIONAL ANTAGONISTS TO THE CENTRAL CANNABINOID RECEPTORS<br/>[FR] UTILISATION DE COMPOSES EN TANT QU'ANTAGONISTES FONCTIONNELS DES RECEPTEURS CANNABINOIDES CENTRAUX
申请人:RES & INNOVATION SOC COOP A R
公开号:WO2003006007A1
公开(公告)日:2003-01-23
The invention refers to the use of saturated fatty acid acylamide derivatives as functional antagonists to the central cannabinoid receptors. These molecules, per se devoid of the psychotropic effects of classic cannabinoids, aminoalkylindoles, endocannabinoids known today, have the ability to behave as functional antagonists of the central cannabinoid receptors, when administered by different routes. For their pharmacological activity they are therefore suitable as drugs in pathological states or disorder which can be controlled through a reduction in the functionality of said receptors or through a reduction of the effect of the same endocannabinoids also caused by a reduced availability or affinity of the receptors.